Monthly Archives: March 2020

Kaskela Law LLC Announces Investigation of Acuity Brands, Inc. (AYI) and Encourages Long-Term Stockholders to Contact the Firm

PHILADELPHIA, PA / ACCESSWIRE / March 26, 2020 / Kaskela Law LLC announces that it is investigating Acuity Brands, Inc. ("Acuity") (NYSE:AYI) on behalf of the company's stockholders.

Acuity stockholders who purchased shares of the Company's stock before April 3, 2017 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (888) 715 – 1740, or online at http://kaskelalaw.com/case/acuity-brands-inc/, for additional information about this investigation and their legal rights and options.

In 2018, a shareholder class action complaint was filed against the Company in federal court on behalf of certain purchasers of Acuity's common stock. Among other things, the shareholder complaint alleged that Acuity violated the federal securities laws by making a series of materially false and misleading statements to shareholders about the Company's ability to maintain sales growth rates.

The firm's investigation seeks to determine whether Acuity's officers and/or directors breached their fiduciary duties to the Company and its stockholders in connection with the above-alleged misconduct.

Acuity shareholders are encouraged to contact Kaskela Law LLC for additional information about this investigation. Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258 – 1585
(888) 715 – 1740
www.kaskelalaw.com
skaskela@kaskelalaw.com

SOURCE: Kaskela Law LLC

ReleaseID: 582601

Bold Ventures Signs Farwell Gold and Base Metal Option Agreement-Closes Non-Brokered Private Placement

Not for distribution to U.S. Newswire Services or for dissemination in the United States

TORONTO, ON / ACCESSWIRE / March 26, 2020 / Bold Ventures Inc. (TSXV:BOL) (the "Company" or "Bold") is pleased to announce it has signed the formal Option Agreement to acquire the Farwell Gold and Base Metal property ("Farwell").

The Farwell claims are located approximately 55 km northwest of Wawa, Ontario. They are road accessible and consist of 103 Cell claims, 6 Multi-Cell claims and 6 Boundary claims comprising approximately 3993 ha or 9867 acres. Wesdome Gold Mines Mishi Open Pit operation, part of the larger Eagle River Complex that includes the Eagle River underground gold mine, lies 5 km south of the Farwell claim group. The Eagle River Mine is situated approximately 25 km to the south of the subject claims (see Bold news release dated January 6, 2020).

The Farwell Property exhibits several desirable attributes. It is a large road-accessible property in a proven gold camp with gold-bearing quartz veins in iron formation along the western extension of a major deformation zone. The presence of deformed ‘Timiskaming' style conglomerates along the gold mineralization trend (i.e. Kirkland Lake, Geraldton) is an attractive exploration target. Volcanogenic Massive Sulphide (VMS) mineralization of anomalous copper (Cu), zinc (Zn), lead (Pb) and gold (Au) is associated with a mafic to felsic volcanic sequence.

The claims are host to several gold and base metal anomalies and occurrences that have yet to be fully explored. The latest recorded exploration work on the property occurred in 2008. A report and maps describing the property, geology and historical work can be found at www.boldventuresinc.com within the Project Details section, Farwell, Ontario.

Bold has the option to earn a 100% interest in the Farwell claims by paying the aggregate sum of $225,000 in cash option payments, issuing an aggregate of 1,650,000 common shares of Bold and completing a total of $1,000,000 of exploration work on the claims over a four year period. On closing, the Company will pay the vendors $20,000 cash and 200,000 shares. The first year's exploration work expenditure is $90,000. The vendors will retain a 3% net smelter royalty in the Farwell Property. Bold will have the right to buy back a 1.5% net smelter royalty in consideration for the payment of $2 million. The Company also has the right of first refusal to purchase the remaining 1.5% NSR. The Option Agreement is subject to TSX Venture Exchange approval. Any common shares issued pursuant to the Option Agreement will be subject to a statutory four month hold period from the date of issuance.

For a full description of the Option agreement visit www.boldventuresinc.com and select the Farwell Project Details on the Farwell, Ontario projects page.

The Company also announces the closing of the final tranche of its non-brokered private placement that was announced in a Bold news release dated February 5, 2020. The Company placed 300,000 working capital units (the "WC Units") for proceeds of $15,000. Each WC Unit was priced at $0.05 and comprises one (1) common share of the Company and one (1) common share purchase warrant (each a "WC Warrant"), with each WC Warrant entitling the holder to acquire one (1) common share at a price of $0.10 until March 25, 2022. The Company placed an aggregate of 2,745,000 WC Units pursuant to the Offering for total gross proceeds of $137,500. The securities issued pursuant to the final closing are subject to a hold period expiring on July 26, 2020. The proceeds from the Offering will be used for general working capital, property acquisitions, exploration and expenses of the Offering.

Bold management and personnel are following the mandated health advisories during the current coronavirus pandemic. The Company is currently planning the 2020 exploration program for the Farwell Project and will monitor the current Covid-19 crisis to ascertain the most appropriate schedule for field activities. The Company and its projects, including the Farwell Gold and Base Metal Project, may be viewed at www.boldventuresinc.com.

The technical information in this news release was reviewed and approved by Gerald D. White, B.Sc., P. Geo., a qualified person (QP) for the purposes of NI 43-101.

About Bold Ventures Inc.

The Company explores for Base and Precious metals in Canada. Bold has options to earn a 100% interest in the Farwell Gold Base Metals project located approx. 55km northwest of Wawa, Ontario and the Wilcorp Gold Project located 14 km east northeast of Atikokan, Ontario. Bold and its subsidiary Rencore Resources Ltd. have extensive holdings comprised of over 15 claim groups in and around the Ring of Fire area of the James Bay Lowlands. The Company has also earned a 10% carried interest in all chromite resources and a 40% working interest in all other metals at the Koper Lake Project and has the option to earn an additional 10% carried interest in chromite and 40% of all other metals. The Koper Lake Project is located within the Ring of Fire and directly adjacent to the Eagles Nest nickel-copper massive sulphide deposit currently in the permitting stage.

For additional information about Bold Ventures and our projects please visit www.boldventuresinc.com or contact Bold Ventures Inc. at 416-864-1456.

"David B Graham"

David B. Graham
President and CEO

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements: This Press Release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions are intended to identify forward-looking statements. Such statements reflect our current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause our actual results to differ materially from the statements made, including those factors discussed in filings made by us with the Canadian securities regulatory authorities. Should one or more of these risks and uncertainties, such actual results of current exploration programs, the general risks associated with the mining industry, the price of gold and other metals, currency and interest rate fluctuations, increased competition and general economic and market factors, occur or should assumptions underlying the forward looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements, except as required by law. Shareholders are cautioned not to put undue reliance on such forward-looking statements.

SOURCE: Bold Ventures Inc.

ReleaseID: 582569

Black Tusk Resources Inc. Submits Drill Permit Application for The McKenzie East Project, Quebec

TORONTO, ON / ACCESSWIRE / March 26, 2020 / Black Tusk Resources Inc. ("Black Tusk" or the "Company) (CSE:TUSK)(OTCPINK:BTKRF)(FRANKFURT:0NB) is pleased to announce that the application for a permit to conduct exploration drilling on the McKenzie East Gold Project has been submitted to Quebec Ministry of Forests, Wildlife and Parks. The application process was prepared by Sulviculture La Verendrye of Amos, Quebec. The location of proposed drilling was determined by Black Tusk's geological team.

The McKenzie East Project permit will allow for the construction of 18 drill pads, 11 water supply stations and 3 kilometres of access trails. Black Tusk anticipates conducting this work during the 2020 exploration season.

Prior to conducting diamond drilling on the property, Black Tusk plans to undertake surface prospecting, mapping and sampling once access to the property is conducive for this work, expected to be later this spring. Areas of interest were determined from the results of the recently completed magnetic survey over the property combined with the results from historic exploration work.

The Company is looking forward to the start of the 2020 exploration season at the McKenzie East Gold Project in Val-d'Or, area, Quebec.

Figure 1 – Diamond drill hole and gold mineralized showing locations from SIGEOM database. For a more detailed picture, please click here: https://www.accesswire.com/media/582447/BLACKTUSK.png

The Company also announces that it has issued 2,000,000 stock options of which 1,600,000 of the issued options were issued to directors and officers of the Company. The options have an exercise price of $0.05 per share and expire on March 24, 2022.

About Black Tusk Resources Inc.

Black Tusk Resources is engaged in mineral exploration of its gold projects in world-class mining regions across Canada. The company currently owns a 100-per-cent undivided interest in 3 separate gold properties. The South Rim Gold Project, situated in the Smithers mining camp B.C., The Golden Valley Project, located 35 kilometres north of La Sarre, West Abitibi, Quebec, and Black Tusk's flagship property, The McKenzie East Gold Project, which is located 30 kilometres north of Val-d'Or, Quebec in the prolific Abitibi greenstone belt.

Perry Grunenberg, P.Geo, a "Qualified Person" as that term is defined under NI 43-101, has reviewed and approved the technical information contained in this news release. Mr. Grunenberg is also a director of the Company.

On behalf of the Board of Directors

Richard Penn

CEO

(778) 384-8923

Forward-looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the business plans for the Company as described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which are available at www.sedar.com.

The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.

SOURCE: Black Tusk Resources Inc

ReleaseID: 582447

Capstone Turbine (NASDAQ: CPST) Secures Order to Upgrade Wastewater Treatment Plant in Roseville, California for Renewable Energy Project

The Order Will Include a Comprehensive Capstone 10-Year Factory Protection Plan (FPP)

VAN NUYS, CA / ACCESSWIRE / March 26, 2020 / Capstone Turbine Corporation (www.capstoneturbine.com) (NASDAQ:CPST), the world's leading clean technology manufacturer of microturbine energy systems, announced today that it received an order for an 800 kilowatt (kW) Signature Series microturbine to upgrade the City of Roseville, California, wastewater treatment plant (WWTP).

The low-emission C800S microturbine system will allow the City of Roseville to yield significant benefits for customers and the environment in the near and long-term. The regional wastewater plant will help officials meet efficiency and sustainability goals by reducing carbon emission, equal to what can be stored in 2,100 acres of forest, and produce clean and green power equal to powering 740 homes.

Cal Microturbine, Capstone's exclusive distributor in California, Washington, Oregon, Idaho, Hawaii and Nevada (www.calmicroturbine.com), secured the order for the digester-gas fueled Capstone C800S microturbine energy system.

"This order is significant as it shows the continued expansion of the biogas sector in the United States," said Darren Jamison, President and Chief Executive Officer of Capstone Turbine Corporation. "Global wastewater treatment projects and other biogas to energy projects like landfills and breweries continue to grow and today make up 15% of our total revenue for the nine months ended December 31, 2019, compared to only 8% in the same period last year," added Mr. Jamison.

Capstone Turbine's innovative microturbine systems have the ability to operate on biogas and other renewable fuels and produce clean and efficient electricity and thermal energy. Capstone microturbines are designed to help end-users improve their environmental impact while meeting critical power and reliability requirements.

"Capstone microturbines meet strict emissions regulations with minimal renewable fuel processing to provide firm, 24/7 renewable power, a major need for grid support in California," said Kenda Brown, President at Cal Microturbine. "Cal Microturbine sees continued growth in the renewable market as clients move to make beneficial use of biogas," added Ms. Brown.

The infrastructure upgrade project will not only increase treatment capacity but will allow officials to build a waste-to-energy cogeneration plant that will produce electricity for onsite use. A five-bay C800 Signature Series microturbine will provide a long-term scalable solution for the project and can be easily expanded in the future to accommodate an increase in site loads. The 800kW Capstone system is expected to be delivered in December of this year, in line with Capstone's recently enacted COVID-19 Business Continuity Plan.

The WWTP will utilize minimally processed digester methane for use in the 800kW Capstone system while the waste heat will be recovered for digester heating. As digester gas production increases, the customer can add an additional 200kW module by populating an unused engine bay within the enclosure, avoiding future site work and reducing costs. Capstone was selected by a national engineering firm due to its value, emissions, and flexibility to easily add an additional 200kW of power. Cal Microturbine is currently working on an identical follow-on project for another municipal digester with the same engineering firm.

About Capstone Turbine Corporation

Capstone Turbine Corporation (www.capstoneturbine.com) (NASDAQ: CPST) is the world's leading producer of highly efficient, low-emission, resilient microturbine energy systems. Capstone microturbines serve multiple vertical markets worldwide, including natural resources, energy efficiency, renewable energy, critical power supply, transportation and microgrids. Capstone offers a comprehensive product lineup, providing scalable systems focusing on 30 kWs to 10 MWs that operate on a variety of gaseous or liquid fuels and are the ideal solution for today's distributed power generation needs. To date, Capstone has shipped over 9,000 units to 73 countries and in FY19, saved customers an estimated $253 million in annual energy costs and 350,000 tons of carbon.

For more information about the company, please visit www.capstoneturbine.com. Follow Capstone Turbine on Twitter, LinkedIn, Instagram, and YouTube.

Forward-Looking Statements

This press release contains "forward-looking statements," as that term is used in the federal securities laws. Forward-looking statements may be identified by words such as "expects," "believes," "objective," "intend," "targeted," "plan" and similar phrases. These forward-looking statements are subject to numerous assumptions, risks and uncertainties described in Capstone's filings with the Securities and Exchange Commission that may cause Capstone's actual results to be materially different from any future results expressed or implied in such statements. Capstone cautions readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Capstone undertakes no obligation, and specifically disclaims any obligation, to release any revisions to any forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

"Capstone" and "Capstone Microturbine" are registered trademarks of Capstone Turbine Corporation. All other trademarks mentioned are the property of their respective owners.

CONTACT:

Capstone Turbine Corporation
Investor and investment media inquiries:
818-407-3628
ir@capstoneturbine.com

Integra Investor Relations
Shawn M. Severson
415-226-7747
cpst@integra-ir.com

SOURCE: Capstone Turbine Corporation

ReleaseID: 582615

ParcelPal Signs Distribution Deal with O2 Canada for Distribution of Masks for Western Canada

VANCOUVER, BC / ACCESSWIRE / March 26, 2020 / ParcelPal Technology Inc. ("ParcelPal" or the "Company"), (PKG:CSE)(FSE:PT0)(OTCPINK:PTNYF) is pleased to announce that it has signed a distribution agreement with O2 Canada ("O2 Canada") for the distribution of its respiratory masks in Western Canada.

Initially, the Company will begin distribution in Vancouver, then roll out to Calgary, Alberta. Customers will be able to shop on O2 Canada's website directly at www.o2canada.com or purchase the masks through the ParcelPal platform and have it delivered directly to them, either same day or on-demand. ParcelPal will begin implementing this requirement for drivers and employees to wear masks along with other current COVID-19 measures. Product will be available to purchase from ParcelPal in the coming weeks.

As COVID-19 cases are saturating nearly all areas of the globe, virtually all health care workers are using these N95 masks. There is also currently a massive shortage of N95 masks in the world, prompting many hospitals to decontaminate and reuse them.

O2 Canada has witnessed triple digit growth in demand for its masks over the past few weeks. Both ParcelPal and O2Canada expect demand for COVID-19 masks to continue to grow at a significant rate, especially during this pandemic.

President and CEO Kelly Abbott commented "The safety and well-being of everyone who interacts with ParcelPal is always our priority. We are actively monitoring the coronavirus (COVID-19) situation and are taking steps to help keep our communities safe. We are delighted to be able to offer this product in this time of great need to consumers and potentially health care workers alike."

About O2 Canada

O2 Canada promises you better respiratory performance and wellbeing through better air. With science, technology and design, we create a mobile, personal and controlled breathing space that improves every breath you take so you can experience more of life. O2 Canada is dedicated to making the world a better place, by bringing innovation to healthcare that goes beyond the ordinary and helping countries that have limited resources.

About ParcelPal Technology Inc.

ParcelPal is a leader in the growing technology and logistics industry. ParcelPal seamlessly connects consumers to businesses, where they have access to the goods they love, anytime, anywhere. Customers can shop at partner businesses and through the ParcelPal technology receive their purchased goods within an hour or the same day. The Company offers on-demand delivery of merchandise from leading retailers, restaurants, medical marijuana dispensaries and liquor stores in Vancouver, Calgary, Saskatoon and soon in major cities Canada-wide.

Sources: https://www.statnews.com/2020/03/10/simple-math-alarming-answers-covid-19/

ParcelPal Website: www.parcelpal.com

The Canadian Securities Exchange ("CSE") or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release that has been prepared by management.

CSE – Symbol: PKG
FSE – Symbol: PT0
OTC – Symbol: PTNYF

Contact: re: Investor Inquiries – info@parcelpal.com

Forward Looking Information

This news release contains forward looking statements relating to the Proposed Transaction, and the future potential of ParcelPal. Forward looking statements are often identified by terms such as "will", "may", "should", "intends", "anticipates", "expects", "plans" and similar expressions. All statements other than statements of historical fact, included in this release are forward looking statements that involve risks and uncertainties. These risks and uncertainties include, without limitation, the risk that the Proposed Transaction will not be completed due to, among other things, failure to execute definitive documentation, failure to complete satisfactory due diligence, failure to receive the approval of the CSE and the risk that ParcelPal will not be successful due to, among other things, general risks relating to the mobile application industry, failure of ParcelPal to gain market acceptance and potential challenges to the intellectual property utilized in ParcelPal. There can be no assurance that any forward looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

The Company cannot guarantee that any forward looking statement will materialize and the reader is cautioned not to place undue reliance on any forward looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward looking statements contained in this news release are expressly qualified by this cautionary statement. The forward looking statements contained in this news release are made as of the date of this news release and the Company will only update or revise publicly any of the included forward looking statements as expressly required by Canadian securities laws.

SOURCE: ParcelPal Technology Inc.

ReleaseID: 582624

AIM ImmunoTech Announces Further Efforts to Establish Clinical Trials Assessing Ampligen as a Potential Protective and Early-Onset Treatment for the Current COVID-19 Pandemic

OCALA, FL / ACCESSWIRE / March 26, 2020 / AIM ImmunoTech (NYSE American:AIM) today announced that it is actively seeking investigators and sites for clinical testing of Ampligen as a protective prophylaxis and an early-onset treatment for COVID-19, the disease caused by the SARS-CoV-2 coronavirus.

The company is targeting the United States, Europe, Asia and Argentina for its clinical trials and, as necessary steps before clinical trials could begin, the company is in the process of soliciting one or more sites and qualified principal investigators in one or more countries. Protocols for potential clinical trial are in the final stages of development. AIM intends, as a next step, to as rapidly as possible seek Institutional Review Board approvals and governmental authorizations to commence the clinical trials of Ampligen as both a protective prophylaxis and an early-onset therapy.

AIM has reached several significant COVID-19 milestones over the past two months:

AIM filed provisional patent applications to secure the company's intellectual property before seeking domestic and international research partners.

Japan's National Institute of Infectious Diseases (NIID) agreed to experiment with Ampligen as a potential treatment for COVID-19. The testing and research will be conducted by laboratories at the NIID and the University of Tokyo. AIM will report immediately upon receipt of results.

AIM engaged ChinaGoAbroad (CGA) to facilitate pre-clinical and clinical trials of Ampligen in the People's Republic of China (PRC).

AIM is in discussions with GP-Pharm in Argentina to advance Ampligen for potential use against COVID-19. Ampligen is an approved drug in Argentina for use against myalgic encephalomyelitis/chronic fatigue syndrome.

AIM is in discussions with myTomorrows and Erasmus MC, Rotterdam – where Ampligen was recently used to treat pancreatic cancer patients – to explore expedited pre-clinical and clinical trials of Ampligen.

"Since the first news of the outbreak, our focus and efforts have been devoted to developing Ampligen as an intranasal and oral protective prophylaxis and as an intravenous early-onset treatment for this highly pathogenic coronavirus. As front-line workers fighting the pandemic around the world know – and as their families know – they are putting their lives on the line every day by working with COVID-19 patients. For example, health care workers account for a reported 13% of cases in Spain. I have a son and a nephew who are doctors, a daughter and a sister who are nurses, three nephews who are EMTs, and one nephew who is a police officer. This fight is personal to me, as it is to countless others around the globe. In the absence of an effective vaccine, the development of early-stage therapies such as Ampligen may be critical both to the health of our front-line workers and to blunt the spread of the pandemic," said AIM CEO Thomas K. Equels.

AIM also continues to await results in the six ongoing clinical trials studying the effects of Ampligen on different types of cancers, where steady progress continues to be made. The company will update stockholders and the market as more information on these studies becomes available. To that point, today the company filed a duly executed amendment to its Material Transfer and Research Agreement with Roswell Park Comprehensive Cancer Center, attaching an exhibit showing the clinical trials currently underway or on deck. Cancer patients are especially at risk with COVID-19. We also recognize that all cancer centers, like all medical facilities, must make the pandemic their priority. Therefore, there is the potential for delays in clinical trial enrollment and reporting in ongoing studies in cancer patients as a consequence of the COVID-19 medical emergency.

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers. AIM's flagship products include the Argentina-approved drug rintatolimod (trade names Ampligen® or Rintamod®) and the FDA-approved drug Alferon N Injection®. Based on results of published, peer-reviewed pre-clinical studies and clinical trials, AIM believes that Ampligen® may have broad-spectrum anti-viral and anti-cancer properties. Clinical trials of Ampligen® include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer and triple negative metastatic breast cancer. These and other potential uses will require additional clinical trials to confirm the safety and effectiveness data necessary to support regulatory approval and additional funding. Rintatolimod is a double-stranded RNA being developed for globally important debilitating diseases and disorders of the immune system.

Cautionary Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate" and similar expressions (as well as other words or expressions referencing future events or circumstances) are intended to identify forward-looking statements. These statements involve a number of risks and uncertainties. For example, significant additional testing and trials will be required to determine whether Ampligen will be effective in the treatment of COVID-19 in humans and no assurance can be given that it will be the case. Some of the world's largest pharmaceutical companies are racing to find a treatment for COVID-19. Even if Ampligen proves effective in combating the virus, no assurance can be given that our actions toward proving this will be given first priority or that, even if Ampligen proves effective, another treatment that eventually proves effective will not make our efforts ultimately unproductive. No assurance can be given that future studies will not result in findings that are different from those reported in studies we are relying on. Operating in foreign countries carries with it a number of risks, including potential difficulties in enforcing intellectual property rights. We cannot assure that our potential foreign operations will not be adversely affected by these risks. With regard to the Company's activities with Ampligen generally, no assurance can be given as to whether current or planned trials will be successful or yield favorable data and the trials are subject to many factors including lack of regulatory approval(s), lack of study drug, or a change in priorities at the institutions sponsoring other trials. In addition, initiation of planned clinical trials may not occur secondary to many factors including lack of regulatory approval(s) or lack of study drug. Even if these clinical trials are initiated, the Company cannot assure that the clinical studies will be successful or yield any useful data or require additional funding. Any forward-looking statements set forth herein speak only as of the date of this press release. The Company does not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. The information found on our website is not incorporated by reference herein and is included for reference purposes only.

Contacts:

Crescendo Communications, LLC
Phone: 212-671-1021
Email: aim@crescendo-ir.com

AIM ImmunoTech Inc
Phone: 800-778-4042
Email: IR@aimimmuno.com

SOURCE: AIM ImmunoTech Inc.

ReleaseID: 582484

Unique Fabricating, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results

AUBURN HILLS, MI / ACCESSWIRE / March 26, 2020 / Unique Fabricating, Inc. ("Unique Fabricating" or the "Company") (NYSE American:UFAB), which engineers and manufactures multi-material foam, rubber, and plastic components utilized in noise, vibration, and harshness management and air/water sealing applications for the automotive and industrial market, today announced its financial results for the fiscal year and fourth quarter ended December 29, 2019.

Fourth Quarter 2019 Financial Results

Net sales of $35.6 million compared to $39.8 million in the fourth quarter of 2018
Net income of $0.0 million or $0.00 per basic and diluted share compared to a net loss of ($0.2) million or ($0.02) per basic and diluted share in the fourth quarter of 2018.
Restructuring charges of $1.0 million primarily related to the closing of the Company's Evansville, Indiana and Bryan, Ohio plants.
Adjusted EBITDA of $4.4 million excluding, among other things, the $1.0 million in restructuring expense, compared to $3.4 million in the fourth quarter of 2018 in which no restructuring expense was incurred. (1)
Total debt reduced by $3.3 million to $47.5 million as of December 29, 2019 compared to $50.8 million as of September 29, 2019 and $55.9 million as of December 30, 2018, as the Company utilized an increase in operating cash generated from higher earnings and decreased use of working capital due to improved inventory and accounts receivable management.

Full Year 2019 Financial Results

Net sales of $152.5 million compared to $174.9 million in 2018.
Net loss of ($9.1) million or ($0.93) per basic and diluted share including a non-cash impairment charge related to Goodwill of ($6.8) million or ($0.70) per basic and diluted share compared to $3.7 million net income or $0.38 per basic and $0.37 per diluted share in 2018.
Adjusted EBITDA of $13.2 million excluding $2.8 million in restructuring expense compared to $17.1 million in 2018, excluding $1.2 million in restructuring expense. (1)
Total debt reduced by $8.4 million to $47.5 million as of December 29, 2019 from $55.9 million as of December 30, 2018.

(1) For a reconciliation of GAAP to Non-GAAP results for Adjusted EBITDA and Adjusted diluted earnings per share please refer to the financial tables below.

"The increase in our fourth quarter adjusted EBITDA to $4.4 million is a clear indicator that the comprehensive cost reduction and organization alignment activities both completed, and in-process are having the intended impact on the business," said Doug Cain, President & CEO. "In the almost six months since joining Unique Fabricating, the Unique team has been executing our comprehensive plans to strengthen the organization, reduce debt, improve operating margins, increase capacity utilization, and aggressively gain market share. As we have reached the end of our restructure and stabilize phase, I am convinced that our ‘Boldly Back on Track' initiative has been fully embraced by all levels of the organization and that our ambitious targets are achievable as we continuously look for improvement and growth opportunities. We enter 2020 with a talented and motivated leadership team and organization, a lean cost-efficient structure, and a clear focus on the key drivers for profitable growth."

Coronavirus Update

Due to the ongoing COVID-19 outbreak with its uncertain near, mid, and longer-term impacts on the Company, our customers, our suppliers, and the industries we serve, we are executing a comprehensive set of actions to prudently manage our resources while keeping our customers supplied with the products they continue to require.

While demand in the automotive segment has been reduced for an indeterminate period, we continue to have customer orders across our various markets and in all our plants. Currently, we are operating our facilities.

We are following the guidelines provided by the various governmental entities in the jurisdictions where we operate and are taking additional measures to protect our employees.

Considering the current decline in demand, we are modifying our shift schedules and plant employee counts, limiting our raw material ordering, and restricting all discretionary spending.

As our supply base is almost exclusively North American, we have not yet seen disruptions in our supply chain.

Due to the inherent uncertainty of the unprecedented and rapidly evolving situation including the duration of the actions taken by the various customers and governments, we are unable to determine the full impact of the COVID-19 situation on our future operations.

Fourth Quarter Financial Summary

Net sales for the quarter ended December 29, 2019 decreased to $35.6 million, down 10.6% or $4.2 million from $39.8 million during the same period last year. The decrease included the loss of net sales of $2.9 million related to several customer platform cancellations plus the end of life for three major program platforms, where the Company did not win the successor business or customers made a change eliminating the Company's product on the platform. We also experienced a $1.0 million loss in sales due to a general decline in industry production volumes and a net sales loss of $0.3 million from a combination of the Fort Smith, Arkansas and Evansville, Indiana plant closures and discontinued work with several major air conditioning customers.

Gross profit for the quarter ended December 29, 2019 was $7.8 million, or 21.9% of total net sales, compared to $8.5 million, or 21.4% of net sales, for the corresponding period last year.

Restructuring expense for the quarter ended December 29, 2019 of $1.0 million was primarily related to the previously announced closure of the Company's Evansville, Indiana and Bryan, Ohio plants compared to no restructuring expense incurred in the same period last year.

Net income for the quarter ended December 29, 2019 was $0.0 million, or $0.00 per basic and diluted share, compared to a net loss of ($0.2) million, or ($0.02) per basic and diluted share, in the fourth quarter of 2018. The improvement in net income for the period was primarily due to the impact of the comprehensive cost reduction and organizational alignment activities offsetting lower net sales.

Adjusted EBITDA for the fourth quarter of 2019 was $4.4 million compared to $3.4 million in the fourth quarter of 2018. This increase is the result of multiple cost reduction activities that began in early 2019 and accelerated in the fourth quarter. Please refer to the financial tables below for a reconciliation of GAAP to Non-GAAP results.

Full Year 2019 Financial Summary

Net sales for the year ended December 29, 2019 were $152.5 million, down 12.8%, or $22.4 million, from $174.9 million during 2018. The decrease included $11.7 million of net sales related to end of life for three major program platforms, where the Company did not win the successor business or customers made a change eliminating the Company's product on the platform, and several other customer platform cancellations. We also experienced a $5.5 million sales loss from the Fort Smith, Arkansas and Evansville, Indiana plant closures and discontinued work with major air conditioning customers. In addition, general industry production declines and other customer sourcing decisions negatively impacted revenue by $5.2 million.

Gross profit for the full year 2019 was $31.5 million, or 20.7% of net sales, compared to $39.3 million, or 22.4% of net sales, for 2018. The decrease in gross profit was primarily related to the decline in net sales and corresponding contribution margin combined with a negative $1.7 million inventory allowance adjustment in the third quarter of 2019.

Restructuring expense for 2019 was $2.8 million with $1.8 million due to the closing of the Company's Evansville, Indiana and Bryan, Ohio facilities and the other $1.0 million due to compensation related salaried restructuring charges of $1.0 million. This compares to $1.2 million of restructuring expense related to the closure of Fort Smith, Arkansas and Port Huron, Michigan plants in 2018.

Inclusive of the $11.3 million in non-recurring charges, net loss for 2019 was ($9.1) million, or ($0.93) per basic and diluted share, compared to net income of $3.7 million, or $0.38 per basic share and $0.37 diluted share, in 2018. The net loss for the period was primarily due to lower sales resulting in a gross profit decline, a Goodwill impairment charge of $6.8 million, restructuring expense of $2.8 million as described above, and an increased interest expense of $0.5 million. Despite lower debt outstanding, higher interest rates, and a non-cash unfavorable mark-to-market charge of $0.6 million recognized on an interest rate swap caused the increase in 2019 interest expense compared to 2018. These negative impacts were partially offset by a $3.0 million reduction in SG&A.

Adjusted EBITDA for 2019 was $13.2 million compared to $17.1 million for 2018. The decrease is primarily a result of lower sales and the corresponding contribution margin loss combined with the $1.7 million inventory allowance adjustment which were partially offset by a $3.0 million reduction in SG&A. Refer to the financial tables below for a reconciliation of GAAP to Non-GAAP results.

Balance Sheet Summary

As of December 29, 2019, the Company had approximately $0.7 million in cash and cash equivalents, compared to December 30, 2018 when the Company had $1.4 million in cash and cash equivalents. Total debt outstanding as of December 29, 2019 was $47.5 million compared to $50.8 million as of September 29, 2019 and $55.9 million as of December 30, 2018, as operating cash generated from earnings and from improved inventory and accounts receivable management was used to pay down outstanding debt during the year.

Under its $30 million Revolving Line of Credit as of December 29, 2019, the Company had unused net liquidity of $6.8 million which is sufficient to operate the business effectively.

Results Conference Call

Unique Fabricating will host a conference call and live webcast to review the quarterly results and provide a corporate update today at 9 a.m. Eastern Time. To access the call, please dial 877-407-8133 (toll free) or 201-689-8040 (international) and if requested, reference conference ID 33811. The conference call will also be webcast live on the Investor Relations section of the company's website at http://uniquefab.investorroom.com.

Following the conclusion of the live call, a replay of the webcast will be available on the Investor Relations section of the Company's website for at least 90 days. A telephonic replay of the conference call will also be available from 12 p.m. ET on March 26, 2020 until 9 a.m. ET on April 9, 2020 by dialing 877-481-4010 (United States) or 919-882-2331 (international) and using the pin number 33811.

About Unique Fabricating, Inc.

Unique Fabricating, Inc. (NYSE American: UFAB) engineers and manufactures components for customers in the automotive and industrial appliance markets. The Company's solutions are comprised of multi-material foam, rubber, and plastic components and utilized in noise, vibration and harshness (NVH) management, acoustical management, water and air sealing, decorative and other functional applications. Unique leverages proprietary manufacturing processes, including die cutting, thermoforming, compression molding, fusion molding, and reaction injection molding to manufacture a wide range of products including air management products, heating ventilating and air conditioning (HVAC), seals, fender stuffers, air ducts, acoustical insulation, door water shields, gas tank pads, light gaskets, topper pads, mirror gaskets and glove box liners. The Company is headquartered in Auburn Hills, Michigan. For more information, visit http://www.uniquefab.com/.

About Non-GAAP Financial Measures

We present Adjusted EBITDA in this press release to provide a supplemental measure of our operating performance. We define Adjusted EBITDA as earnings before interest expense, income tax expense, depreciation and amortization expense, non-cash stock awards, goodwill impairment, non-recurring integration expense, transaction fees related to our acquisitions, restructuring expenses, and one-time consulting and licensing ERP system implementation costs as we implement a new ERP system at all locations. We believe that Adjusted EBITDA is a useful performance measure used by us to facilitate a comparison of our operating performance and earnings on a consistent basis from period-to-period and to provide for a more complete understanding of factors and trends affecting our business than measures under generally accepted accounting principles in the United States of America (GAAP) can provide alone. Our board and management also use Adjusted EBITDA as one of the primary methods for planning and forecasting overall expected performance and for evaluating on a quarterly and annual basis actual result against such expectations, and as a performance evaluation metric in determining achievement of certain compensation programs and plans for Company management. In addition, the financial covenants in our senior secured credit facility are based on Adjusted EBITDA, as presented in this press release, subject to dollar limitations on certain adjustments and certain other addbacks permitted by our senior secured credit facility. These non-GAAP financial measures may have limitations as analytical tools, and these measures should not be considered in isolation as a substitute for analysis of Unique Fabricating's results as reported under GAAP.

Safe Harbor Statement

Except for the historical information contained herein, the matters discussed in this news release include forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. Forward-looking statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause the Company's or the Company's industry's actual results, levels of activity, performance or achievements including statements relating to the Company's 2019 Outlook to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by this press release. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook," and similar expressions are used to identify these forward looking statements. Such forward-looking statements include statements regarding, among other things, our expectations about revenue, Adjusted EBITDA, and adjusted diluted earnings per share. All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, those discussed in our Annual Report on Form 10-K for the year ended December 29, 2019 filed with the Securities and Exchange Commission and in particular the Section entitled "Risk Factors", as well as any updates to those risk factors filed from time to time in our periodic and current reports filed with the Securities and Exchange Commission. All statements contained in this press release are made as of the date of this press release, and Unique Fabricating does not intend to update this information, unless required by law. Reference to the Company's website above does not constitute incorporation of any of the information thereon into this press release.

Investor Contact:

FNK IR
Rob Fink
(646) 809-4049
Rob@fnkir.com

UNIQUE FABRICATING, INC.
Condensed Consolidated Statements of Operations (Unaudited)
(In thousands, except per share amounts)

 

 
Fifty-Two Weeks Ended December 29, 2019
 
 
Fifty-Two Weeks Ended December 30, 2018
 
 
Fifty-Two Weeks Ended December 31, 2017
 

Net sales

 
$
152,489
 
 
$
174,910
 
 
$
175,288
 

Cost of sales

 
 
120,981
 
 
 
135,575
 
 
 
135,234
 

Gross profit

 
 
31,508
 
 
 
39,335
 
 
 
40,054
 

Selling, general, and administrative expenses

 
 
26,751
 
 
 
29,781
 
 
 
29,767
 

Impairment of goodwill

 
 
6,760
 
 
 

 
 
 

 

Restructuring expenses

 
 
2,752
 
 
 
1,156
 
 
 

 

Operating (loss) income

 
 
(4,755
)
 
 
8,398
 
 
 
10,287
 

Non-operating (expense) income

 
 
 
 
 
 
 
 
 
 
 
 

Other (expense) income, net

 
 
11
 
 
 
(59
 
 
 
79
 

Interest expense

 
 
(4,287
)
 
 
(3,778
)
 
 
(2,746
)

Total non-operating expense, net

 
 
(4,276
)
 
 
(3,837
)
 
 
(2,667
)

(Loss) income – before income taxes

 
 
(9,031
)
 
 
4,561
 
 
 
7,620
 

Income tax expense

 
 
37
 
 
 
862
 
 
 
1,133
 

Net (loss) income

 
$
(9,068
)
 
$
3,699
 
 
$
6,487
 

Net (loss) income per share

 
 
 
 
 
 
 
 
 
 
 
 

Basic

 
$
(0.93
)
 
$
0.38
 
 
$
0.67
 

Diluted

 
$
(0.93
)
 
$
0.37
 
 
$
0.66
 

Cash dividends declared per share

 
$
0.05
 
 
$
0.60
 
 
$
0.60
 

UNIQUE FABRICATING, INC.
Condensed Consolidated Balance Sheets (Unaudited)
(In thousands)

 

 
December 29,
2019
 
 
December 30,
2018
 

Assets

 
 
 
 
 
 

Current assets

 
 
 
 
 
 

Cash and cash equivalents

 
$
650
 
 
$
1,410
 

Accounts receivable – net

 
 
24,701
 
 
 
30,831
 

Inventory – net

 
 
13,047
 
 
 
16,286
 

Prepaid expenses and other current assets:

 
 
 
 
 
 
 
 

Prepaid expenses and other

 
 
2,108
 
 
 
2,511
 

Refundable taxes

 
 
1,049
 
 
 
983
 

Assets held for sale

 
 
1,003
 
 
 

 

Total current assets

 
 
42,558
 
 
 
52,021
 

Property, plant, and equipment – net

 
 
23,415
 
 
 
25,078
 

Goodwill

 
 
22,111
 
 
 
28,871
 

Intangible assets- net

 
 
11,625
 
 
 
15,568
 

Other assets

 
 
 
 
 
 
 
 

Investments – at cost

 
 
1,054
 
 
 
1,054
 

Deposits and other assets

 
 
226
 
 
 
199
 

Deferred tax asset

 
 
679
 
 
 
496
 

Total assets

 
$
101,668
 
 
$
123,287
 

Liabilities and Stockholders' Equity

 
 
 
 
 
 
 
 

Current liabilities

 
 
 
 
 
 
 
 

Accounts payable

 
$
9,324
 
 
$
11,465
 

Current maturities of long-term debt

 
 
2,847
 
 
 
3,350
 

Income taxes payable

 
 

 
 
 
41
 

Accrued compensation

 
 
1,225
 
 
 
2,848
 

Other accrued liabilities

 
 
1,979
 
 
 
1,432
 

Total current liabilities

 
 
15,375
 
 
 
19,136
 

Long-term debt – net of current portion

 
 
33,220
 
 
 
34,668
 

Line of credit-net

 
 
11,418
 
 
 
17,905
 

Other long-term liabilities

 
 
1,324
 
 
 
395
 

Deferred tax liability

 
 
871
 
 
 
2,295
 

Total liabilities

 
 
62,208
 
 
 
74,399
 

Stockholders' Equity

 
 
 
 
 
 
 
 

Common stock, $0.001 par value – 15,000,000 shares authorized and 9,779,147 and 9,779,147 issued and outstanding at December 29, 2019 and December 30, 2018, respectively

 
 
10
 
 
 
10
 

Additional paid-in-capital

 
 
46,011
 
 
 
45,881
 

Retained earnings (accumulated deficit)

 
 
(6,561
)
 
 
2,997
 

Total stockholders' equity

 
 
39,460
 
 
 
48,888
 

Total liabilities and stockholders' equity

 
$
101,668
 
 
$
123,287
 

UNIQUE FABRICATING, INC.
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In thousands)

 

 
Fifty-Two Weeks Ended December 29, 2019
 
 
Fifty-Two Weeks Ended December 30, 2018
 

Cash flows from operating activities

 
 
 
 
 
 

Net (loss) income

 

(9,068
)
 

3,699
 

Adjustments to reconcile net income to net cash provided by operating activities:

 
 
 
 
 
 
 
 

Impairment of goodwill

 
 
6,760
 
 
 

 

Inventory allowance

 
 
1,742
 
 
 

 

Depreciation and amortization

 
 
6,863
 
 
 
6,630
 

Amortization of debt issuance costs

 
 
177
 
 
 
147
 

Loss (gain) on sale of assets

 
 
68
 
 
 
(138
)

Loss on extinguishment of debt

 
 

 
 
 
59
 

Bad debt adjustment

 
 
243
 
 
 
13
 

Loss (gain) on derivative instrument

 
 
578
 
 
 
452
 

Stock option expense

 
 
130
 
 
 
131
 

Deferred income taxes

 
 
(1,153
)
 
 
(291
)

Changes in operating assets and liabilities that provided (used) cash:

 
 
 
 
 
 
 
 

Accounts receivable

 
 
5,888
 
 
 
(3,641
)

Inventory

 
 
2,584
 
 
 
45
 

Prepaid expenses and other assets

 
 
(570
)
 
 
1,212
 

Accounts payable

 
 
(1,104
)
 
 
1,008
 

Accrued and other liabilities

 
 
(1,117
)
 
 
104
 

Net cash provided by operating activities

 
 
12,021
 
 
 
9,430
 

Cash flows from investing activities

 
 
 
 
 
 
 
 

Purchases of property and equipment

 
 
(2,759
)
 
 
(5,393
)

Proceeds from sale of property and equipment

 
 
119
 
 
 
904
 

Net cash used in investing activities

 
 
(2,640
)
 
 
(4,489
)

Cash flows from financing activities

 
 
 
 
 
 
 
 

Net change in bank overdraft

 
 
(1,037
)
 
 
(1,251
)

Proceeds from debt

 
 
1,300
 
 
 
10,132
 

Payments on term loans

 
 
(3,350
)
 
 
(2,962
)

(Repayment) proceeds from revolving credit facilities, net

 
 
(6,565
)
 
 
(4,422
)

Debt issuance costs

 
 

 
 
 
(634
)

Proceeds from exercise of stock options and warrants

 
 

 
 
 
38
 

Distribution of cash dividends

 
 
(489
)
 
 
(5,862
)

Net cash used in financing activities

 
 
(10,141
)
 
 
(4,962
)

Net decrease in cash and cash equivalents

 
 
(760
)
 
 
(21
)

Cash and cash equivalents – beginning of period

 
 
1,410
 
 
 
1,431
 

Cash and cash equivalents – end of period

 

650
 
 

1,410
 

Supplemental disclosure of cash flow Information – cash paid for

 
 
 
 
 
 
 
 

Interest

 

4,104
 
 

3,575
 

Income taxes

 

438
 
 

1,339
 

UNIQUE FABRICATING, INC.
Reconciliation of GAAP Net Income to Adjusted EBITDA

 

 
Thirteen Weeks Ended December 29, 2019
 
 
Thirteen Weeks Ended December 30, 2018
 
 
Thirteen Weeks Ended December 31, 2017
 
 
Fifty-Two Weeks Ended December 29, 2019
 
 
Fifty-Two Weeks Ended December 30, 2018
 
 
Fifty-Two Weeks Ended December 31, 2017
 

 

 
(In thousands)
 

Net (loss) income

 

8
 
 

(191
)
 

2,056
 
 

(9,068
)
 

3,699
 
 

6,487
 

Plus: Interest expense, net

 
 
706
 
 
 
1,345
 
 
 
657
 
 
 
4,286
 
 
 
3,778
 
 
 
2,746
 

Plus: Income tax (benefit) expense

 
 
635
 
 
 
163
 
 
 
(724
)
 
 
37
 
 
 
862
 
 
 
1,133
 

Plus: Depreciation and amortization

 
 
1,768
 
 
 
1,683
 
 
 
1,616
 
 
 
7,041
 
 
 
6,630
 
 
 
6,320
 

Plus: Non-cash stock award

 
 
12
 
 
 
33
 
 
 
35
 
 
 
130
 
 
 
131
 
 
 
150
 

Plus: Non-recurring expenses

 
 

 
 
 
71
 
 
 
127
 
 
 
82
 
 
 
200
 
 
 
158
 

Plus: Goodwill impairment

 
 

 
 
 

 
 
 

 
 
 
6,760
 
 
 

 
 
 

 

Plus: Transaction fees

 
 

 
 
 

 
 
 

 
 
 

 
 
 
27
 
 
 
23
 

Plus: Management fees

 
 
56
 
 
 

 
 
 

 
 
 
225
 
 
 

 
 
 

 

Plus: Restructuring expenses

 
 
935
 
 
 

 
 
 

 
 
 
2,752
 
 
 
1,156
 
 
 

 

Plus: One-time consulting and licensing ERP system implementation costs

 
 
283
 
 
 
202
 
 
 
200
 
 
 
932
 
 
 
724
 
 
 
1,015
 

Plus: Debt extinguishment costs

 
 

 
 
 
59
 
 
 

 
 
 

 
 
 
59
 
 
 

 

Less: Gain on sale of building

 
 

 
 
 
(143
)
 
 

 
 
 

 
 
 
(143
)
 
 

 

Adjusted EBITDA

 

4,403
 
 

3,222
 
 

3,967
 
 

13,177
 
 

17,123
 
 

18,032
 

SOURCE: Unique Fabricating, Inc.

ReleaseID: 582608

Embraer S.A. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 26, 2020 / Embraer S.A. (NYSE:ERJ) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 26, 2020 at 9:30 AM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/60571

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 582635

Top 10 Rising Stars in Cosmetic Dentistry

NEW YORK, NY / ACCESSWIRE / March 26, 2020 / The significant rise in the popularity of cosmetic dentistry in the past couple of years presents customers and patients with a number of benefits. This growth helps drive the quality of services and at more affordable prices. However, the higher number of cosmetic dentists can also make it challenging for people to choose where to go for their oral healthcare. This is your quick guide to the top 10 cosmetic dentists of 2020:

Dr. Robert Soto

With his years of experience, it's no surprise that patients from all over the country and even from around the world are traveling for Dr. Robert Soto's dentistry services. He has been serving as a cosmetic dentist in the San Francisco Bay Area for over 12 years. Young professionals, CEOs, and NBA superstars are among the clients flashing his porcelain veneers.

Dr. Yahya Mansour

Dr. Yahya Mansour practices dentistry with the philosophy that "It's about more than the teeth." Probably more than any other person, he knows how a beautiful and confident smile can change lives. And he backs that up with an impressive list of educational and professional attainments. He graduated from the prestigious University of the Pacific. He earned the Fellowship in the International Congress of Oral Implantologists (FICOI) in 2013, then went on to get his Diplomate status. This is an achievement held by only 2,000 dentists in the entire world. Dr. Mansour later earned his Diplomate status in the ICOI in 2017 and his Fellowship in the Academy of General Dentistry in April 2018. The latter distinction is held by only 7% of all dentists.

Dr. James Heaton

Dr. James Heaton uses his passion for dentistry to create beautiful smiles and help change lives for his clients. He earned his Doctor of Dental Surgery degree at Ohio State University, where he received multiple awards. Even as a student, his passion for the field was evident. He had the opportunity to present his research in dental aesthetics to colleagues in Barcelona, Spain. He has over ten years of cosmetic dentistry practice, specifically in Arizona. Above all else, he is a family man who enjoys spending time with his wife and kids.

Dr. Chris Hill

Dr. Chris Hill understands and works with the connection of the smile to the youthful appearance of the face. He utilizes his love for and skills in photography to showcase his work. His area of expertise includes cosmetic dentistry, TMJ treatment, and implant dentistry. In cosmetic dentistry, he is trained in invisalign, porcelain veneers, and full reconstruction. Dr. Hill is a Fellow of the Las Vegas Institute and is a candidate for Accreditation in the American Academy of Cosmetic Dentistry.

Dr. Matthew J Harmon

Dr. Matthew J Harmon combines impeccable clinical skills with genuine compassion for others. These qualities allow him to masterfully design each tooth to fit not only the needs but also the personality of each client. By using the latest in digital technology (Cerec Primescan and mills), he can provide you with a smile makeover in less time than any of the competition. We're talking completed cases in days instead of weeks.

Dr. Rick Kernagis

Dr. Rick Kernagis graduated from the University of Florida College of Dentistry in 1999. His professional accomplishments attest to his impressive skills and abilities in the field. He is an active member of the American Academy of Cosmetic Dentistry, International Congress of Oral Implantologists, American Orthodontic Society, American Academy of Facial Esthetics, and Smile Virtual Specialist.

Dr. Weston Spencer

Dr. Weston Spencer practices cosmetic and restorative dentistry in San Diego, California. He graduated from Loma Linda Dental School in 2010. Since then, he has built a career on seeking out the best that education and technology. This enables him to provide his patients with the absolute top quality services. You also won't find a more modern office with an incredibly calming feel than at Dr. Spencer's. As an example of his use of cutting-edge technology, he offers virtual consultations so he can help patients with their smiles without them having to go into his office.

Dr. Darren Greenhalgh

Dr. Darren Greenhalgh believes that smiles are timeless, teeth are not! Building others' confidence for the past 20 years is what makes him smile. Other than spending time building confidence in his patients' lives, he enjoys lecturing internationally on technology used in smile design and has had the opportunity to mentor and coach many colleagues in the field of dentistry. When not obsessing about dentistry he enjoys spending time with his family whether at home on the farm or outside skiing, rock climbing, surfing, or anything whitewater.

Dr. Taylor Rice

Dr. Taylor Rice was raised in Orange County, California, and practices dentistry there. He has a passion for designing smiles and uses the best technology for the benefit of his patients. Dr. Rice has received extensive training in the most conservative techniques. A dependable dentist with a big heart, he travels to the Dominican Republic for dental humanitarian work.

Dr. Andrew Bateman

Dr. Andrew Bateman has the philosophy that to fix a tooth is rewarding, but to change a smile is life-changing. His goal is to build someone's confidence through dentistry. The young, up-and-coming cosmetic dentist has completed advanced training in cosmetic dentistry and was trained under some of the best cosmetic dentists in the world. Dr. Bateman is a member of numerous prestigious organizations such as the ADA, the UDA, the AGD, the AAACD, and many others.

For more information please email dillon@smilevirtual.com

SOURCE: Smile Virtual

ReleaseID: 582463

Rekor Appoints Susan Crandall Chief Marketing Officer

Seasoned industry marketing executive joins company to lead marketing and business development growth

COLUMBIA, MD / ACCESSWIRE / March 26, 2020 / Rekor Systems, Inc. (NASDAQ:REKR) ("Rekor") (the "Company"), a Nasdaq company focused on bringing smarter, faster, cost-competitive solutions to the worlds of smart cities, public safety and customer experience, today announced that Susan Crandall has joined the Company as its Chief Marketing Officer (CMO). Bringing significant marketing and business development experience at large multi-national companies, she is expected to guide the Company through its next major phase of growth.

"No one is better suited than Susan to join our executive leadership team and help our company begin to roll out our go-to-market strategy," said Robert A. Berman, president and CEO, Rekor. "She knows the technology, industry landscape, dynamics and trends to spot, and is prepared to anticipate and act on the opportunities that will be critical to achieving our strategic growth initiatives. And as a seasoned industry marketing executive, she is intimately familiar with the opportunities relating to our solutions for smart cities, public safety and customer experience."

Crandall brings to Rekor decades of experience leading marketing and business development initiatives for some of the world's largest public safety brands, including serving as Director of Global Marketing at Motorola Solutions, Inc. and Senior Director of Marketing at LexisNexis Risk Solutions, as well as other companies, such as VaaS International, the parent company of Vigilant Solutions and Digital Recognition Network. As Vice President of Marketing and Legislative Affairs for VaaS International, she led all marketing and legislative affairs strategies for the company and played an integral role in helping their leadership team to position the company for its $445 million acquisition by Motorola Solutions in January 2019.

Throughout her two decades of business development and marketing leadership experience, Crandall has fused her creativity and entrepreneurial drive to help organizations tell impactful stories to their key audiences, fueling brand awareness and consistently generating market growth. She offers Rekor a depth and breadth of knowledge in marketing, communications and brand strategy. She has extensive experience as an early adopter in social media and digital marketing efforts and a track record of success in leading government and public relations initiatives. Additionally, she brings a critical understanding of a broad array of markets, including Government and Public Safety, Corporate Security, Financial Services, Insurance and Parking, in each of which she consistently implemented aggressive business plans to meet and exceed revenue and retention goals.

"Rekor is a company I've admired for their ability to transform the vehicle recognition industry through their artificial intelligence and deep machine learning solutions. I'm thrilled to join the company at this point in its strategic evolution, with such great momentum already behind the business," said Crandall. "Rekor's technology and pricing are disruptive, and it's poised to completely redefine how vehicle recognition is used to increase public safety and improve the customer experience. I am excited to roll up my sleeves and work with my team alongside Rekor's leadership and its strong bench of subject matter experts. Together, we can ensure that all of Rekor's innovative solutions are prioritized in the minds of new and existing customers as the solutions that best meet their needs."

Crandall holds a B.A. from Dartmouth College and a J.D. from George Mason University School of Law.

To learn more about Rekor, please visit our website.

About Rekor Systems, Inc.

Rekor Systems, Inc. is a publicly traded company listed on Nasdaq (REKR) with headquarters in Columbia, Maryland. Rekor is focused on bringing smarter, faster, cost-competitive solutions to the worlds of smart cities, public safety and customer experience. With a strong presence in over seventy countries across the world, we use the power of artificial intelligence to provide actionable, vital information for our clients. Whether it's using machine learning software to give those who protect us better tools to keep us safe, or through solutions tailored to improving the everyday lives of everyday people, Rekor has the tech, and the expertise, for the job. At Rekor, we strive to make the impossible … possible. To learn more please visit our website: https://rekorsystems.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. Other than statements of historical facts, all statements contained in this press release are forward-looking statements, including particularly statements regarding our future results of operations and financial position, business strategy, prospective products and services, timing and likelihood of success, plans and objectives of management for future operations, and future results of current and anticipated products and services. These statements involve uncertainties, such as known and unknown risks, and are dependent on other important factors that may cause our actual results, performance or achievements to be materially different from the future results, performance or achievements we express or imply. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. All forward-looking statements contained in this press release speak only as of the date on which they were made, are based on management's assumptions and estimates as of such date and are subject to a number of risks, uncertainties and assumptions, including those described under the sections in our Annual and Quarterly Reports filed with the Securities and Exchange Commission. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. We undertake no obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events, or otherwise.

Media Contact:

Matthew Bretzius
FischTank Marketing and PR
matt@fischtankpr.com

Investor Contact:

Charles Degliomini
Rekor Systems, Inc.
ir@rekorsystems.com

SOURCE: Rekor Systems, Inc.

ReleaseID: 582490